Document Classification

Section Type: RESULTS

Text: Decline in areal BMD, as measured by dual-energy x-ray absorptiometry, in the exemestane group compared with the placebo group occurred at the lumbar spine (-24 % [95 % CI -31 to -17] exemestane vs -05 % [-11 to 02] placebo ; difference -19 %, 95 % CI -29 to -10 ; p < 00001), total hip (-18 % [-23 to -12] exemestane vs -06 % [-11 to -01] placebo ; difference -12 %, -19 to -04 ; p = 0004), and femoral neck (-24 % [-32 to -17] exemestane vs -08 % [-15 to 01] placebo ; difference -16 %, -27 to -06 ; p = 0002).